Skip to main content

Table 4 Outcomes of non-pancreaticoduodenectomy pancreatic surgical patients

From: Establishing an open and robotic pancreatic surgery program in a level 1 trauma center community teaching hospital and comparing its outcomes to high-volume academic center outcomes: a retrospective review

Outcome

DPS

N (of 16)

PNCG

N (of 7)

PNRCJ

N (of 1)

DPPHR

N (of 1)

TP

N (of 1)

R1 resection

0 (*0%)

Reoperation

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Chem Leak

5 (31%)

0 (0%)

0 (0%)

0 (0%)

POPF

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Bile Leak

0 (0%)

0 (0%)

SSI

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

DGE

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

CD III–IV

0 (0%)

1 (14%)

0 (0%)

0 (0%)

1 (100%)

Readmission

2 (13%)

1 (14%)

1 (100%)

1 (100%)

0 (0%)

Mortality

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

  1. CD III–IV Clavien–Dindo grades III–IV complication, Chem Leak Biochemical pancreatic leak, DGE Delayed gastric emptying, DPPHR Duodenum-preserving pancreatic head resection, DPS Distal pancreatectomy with splenectomy, PNCG Transgastric pancreatic necrosectomy with cyst gastrostomy, PNRCJ Pancreatic necrosectomy with Roux-en-Y cyst jejunostomy, POPF Grade B or C postoperative pancreatic fistula, R1 Microscopic residual tumor, SSI Surgical site infection, TP Total pancreatectomy
  2. *This rate only applies to the nine DPS cases performed for cancer